SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 482.07M
March 31, 2026 465.94M
December 31, 2025 455.21M
September 30, 2025 451.46M
June 30, 2025 431.30M
March 31, 2025 412.79M
December 31, 2024 399.73M
September 30, 2024 384.41M
June 30, 2024 371.62M
March 31, 2024 377.96M
December 31, 2023 373.68M
September 30, 2023 361.17M
June 30, 2023 364.09M
March 31, 2023 348.65M
December 31, 2022 342.52M
September 30, 2022 335.91M
June 30, 2022 332.60M
March 31, 2022 338.68M
December 31, 2021 335.69M
September 30, 2021 339.00M
June 30, 2021 324.74M
March 31, 2021 299.94M
December 31, 2020 297.72M
September 30, 2020 299.91M
June 30, 2020 314.67M
Date Value
March 31, 2020 328.03M
December 31, 2019 327.49M
September 30, 2019 321.00M
June 30, 2019 300.40M
March 31, 2019 289.38M
December 31, 2018 276.02M
September 30, 2018 259.63M
June 30, 2018 247.96M
March 31, 2018 236.28M
December 31, 2017 229.14M
September 30, 2017 215.74M
June 30, 2017 214.22M
March 31, 2017 200.46M
December 31, 2016 184.39M
September 30, 2016 179.50M
June 30, 2016 165.50M
March 31, 2016 161.17M
December 31, 2015 156.35M
September 30, 2015 151.62M
June 30, 2015 148.75M
March 31, 2015 148.02M
December 31, 2014 147.91M
September 30, 2014 145.34M
June 30, 2014 140.36M
March 31, 2014 133.32M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Globus Medical, Inc. 1.217B
Baxter International, Inc. 2.932B
DexCom, Inc. 1.361B
Haemonetics Corp. 451.54M
ICU Medical, Inc. 615.07M